Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
13 hedge funds and large institutions have $218K invested in Biocept, Inc. in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
126% more capital invested
Capital invested by funds: $96.4K → $218K (+$122K)
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
18% more funds holding
Funds holding: 11 → 13 (+2)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$142K |
| 2 |
VF
Virtu Financial
New York
|
+$16.6K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$15.3K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.7K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$12.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$54.3K |
| 2 |
BFM
Boothbay Fund Management
New York
|
-$28.5K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.91K |
| 4 |
JP Morgan Chase
New York
|
-$324 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Alyeska Investment Group
Chicago,
Illinois
| $147K | +$142K | +117,647 | New |
|
|
VF
2
Virtu Financial
New York
| $17K | +$16.6K | +13,777 | New |
|
|
TSS
3
Two Sigma Securities
New York
| $15.9K | +$15.3K | +12,718 | New |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| $13.1K | +$12.7K | +10,504 | New |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $13K | +$12.5K | +10,406 | New |
|
6
BlackRock
New York
| $6.58K | – | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $4.75K | -$1.91K | -1,587 | -29% |
|
8
Group One Trading
Chicago,
Illinois
| $338 | – | – | – |
|
9
UBS Group
Zurich,
Switzerland
| $155 | +$149 | +124 | New |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $41 | – | – | – |
|
11
US Bancorp
Minneapolis,
Minnesota
| $23 | – | – | – |
|
12
Wells Fargo
San Francisco,
California
| $14 | +$8 | +7 | +175% |
|
|
AFM
13
Anson Funds Management
Dallas,
Texas
| – | -$54.3K | -44,861 | Closed |
|
|
BFM
14
Boothbay Fund Management
New York
| – | -$28.5K | -23,529 | Closed |
|
|
15
JP Morgan Chase
New York
| – | -$324 | -268 | Closed |
|
BIOC Hedge Fund Activity: Q3 2023 in Review
13 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q3 2023, worth a combined $218K — up 126% from $96.4K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new BIOC positions and 4 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $142K. The largest seller was Anson Funds Management, exiting entirely with an estimated $54.3K sold.
- 13 institutional investors held Biocept, Inc. (BIOC) as of Q3 2023, up from 11 in Q2 2023.
- Funds reported $218K of Biocept, Inc. stock for Q3 2023, up 126% quarter-over-quarter.
- 6 funds opened new Biocept, Inc. positions in Q3 2023 and 4 closed out, a net change of +2 holders.
- The largest Biocept, Inc. buyer in Q3 2023 was Alyeska Investment Group, an estimated $142K added.
- The largest Biocept, Inc. seller in Q3 2023 was Anson Funds Management, an estimated $54.3K sold.
Based on aggregated 13F filings for Q3 2023.